TITO R MENDOZA to Treatment Outcome
This is a "connection" page, showing publications TITO R MENDOZA has written about Treatment Outcome.
Connection Strength
0.162
-
The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer. 2014 Feb; 12(1):41-9.
Score: 0.026
-
Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006 May; 10(4):353-61.
Score: 0.015
-
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol. 2020 02; 21(2):e97-e103.
Score: 0.010
-
Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269.
Score: 0.010
-
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative. Lancet Oncol. 2018 03; 19(3):e173-e180.
Score: 0.009
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.009
-
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607.
Score: 0.009
-
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
Score: 0.009
-
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
Score: 0.008
-
Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma. 2015 May; 56(5):1335-41.
Score: 0.007
-
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65.
Score: 0.006
-
The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res. 2011 Oct; 20(8):1159-67.
Score: 0.006
-
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000.
Score: 0.005
-
The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med. 2010 Mar; 11(3):337-46.
Score: 0.005
-
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
Score: 0.005
-
An urban community's preferences for hypothetical outcomes of analgesic pain treatment. J Pain Symptom Manage. 2006 Nov; 32(5):470-7.
Score: 0.004
-
Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer. 2006 Jul 01; 107(1):207-14.
Score: 0.004
-
The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control. Support Care Cancer. 2005 Sep; 13(9):708-14.
Score: 0.004
-
Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004 Dec 15; 22(24):4918-25.
Score: 0.004
-
Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47.
Score: 0.004
-
Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series. Clin J Pain. 2004 May-Jun; 20(3):195-7.
Score: 0.003
-
A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr; 65(1):87-92.
Score: 0.002